cytokine induced memory-like nk cells
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2020 (NCT04354025)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07274449 | Phase 1/Phase 2 (Phase 2) | May 8, 2025 | Nanjing University |
| NCT04893915 | Phase 2 | Dec 31, 2021 | Washington University in St. Louis, Wugen, Inc. |
| NCT04354025 | Phase 2 | Jul 31, 2020 | Washington University in St. Louis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 2 | 2 | 1 | 2020 |
| Nanjing University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Wugen, Inc. | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1